Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Valsartan Amlodipine Randomized Trial.

Trial Profile

Valsartan Amlodipine Randomized Trial.

Phase of Trial: Phase III

Latest Information Update: 12 Jan 2012

At a glance

  • Drugs Amlodipine (Primary) ; Valsartan (Primary)
  • Indications Cardiovascular disorders; Essential hypertension
  • Focus Therapeutic Use
  • Acronyms VART
  • Most Recent Events

    • 12 Jan 2012 Planned End Date changed to 1 Dec 2008 as reported by University Hospital Medical Information Network - Japan.
    • 29 Aug 2009 Results presented at ESC Congress 2009: Annual Congress of the European Society of Cardiology.
    • 06 Jul 2007 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top